Dexamethasone and 1,25(OH)2 Vitamin D3 Modulate the Synthesis of Insulin-like Growth Factor-I in Osteoblast-like Cells
Overview
Authors
Affiliations
In the present study, we have shown that insulin-like growth factor-I (IGF-I) was released by primary cultures of rat osteoblast-like (ROB) cells into the conditioned medium (CM). Dexamethasone (DEX) caused a dose-dependent inhibition of the IGF-I. At 10(-8) M, DEX reduced IGF-I level to 70% of the control value (P less than 0.05); at 10(-7) M DEX, the IGF-I level was further reduced to 60% of the control (P less than 0.01). The active vitamin D metabolite 1,25-dihydroxycholecalciferol [1,25(OH)2D3] slightly increased the IGF-I level, but the increase was not statistically significant. However, in combined treatments of 10(-7) M DEX and 10(-8) M of 1,25(OH)2D3, the inhibition of DEX was partially antagonized by the presence of 1,25(OH)2D3. Studies with metabolically radiolabeled IGF-I by immunoprecipitation indicated the changes of IGF-I in the CM reflected synthesis of the protein by the cells. The alteration of IGF-I level may mediate some of the actions of these steroid hormones on bone cells.
Perez-Campo F, May T, Zauers J, Sanudo C, Delgado-Calle J, Arozamena J J Bone Miner Metab. 2016; 35(2):150-160.
PMID: 27038990 DOI: 10.1007/s00774-016-0753-z.
Ramajayam G, Vignesh R, Karthikeyan S, Senthil Kumar K, Karthikeyan G, Veni S Mol Cell Biochem. 2012; 368(1-2):77-88.
PMID: 22673962 DOI: 10.1007/s11010-012-1345-4.
Vitamin D metabolism and action in human bone marrow stromal cells.
Zhou S, LeBoff M, Glowacki J Endocrinology. 2009; 151(1):14-22.
PMID: 19966181 PMC: 2803155. DOI: 10.1210/en.2009-0969.
Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.
Maruotti N, Corrado A, Grano M, Colucci S, Cantatore F Rheumatol Int. 2008; 29(6):667-72.
PMID: 18989673 DOI: 10.1007/s00296-008-0755-9.
Abdallah B Cell Mol Biol Lett. 2006; 11(4):461-74.
PMID: 17001448 PMC: 6275977. DOI: 10.2478/s11658-006-0038-y.